Highlights Seven products are now in stock and available to purchase at precisionpeptidecompany.com: BPC, KPV, Ageless, Chill, Blue, Hair and The Recovery Patch. The Recovery Patch is the Company’s first transdermal peptide product available at retail, providing a needle-free format that requires no mixing, no measuring and no cold storage. All 50 U.S. states can order through the platform. LegitScript Healthcare Merchant Certification supports compliance, consumer-safety, payment-processing and advertising standards. GLP-1, Sermorelin and NAD+ protocols are listed on the platform as coming soon, supported by the Company’s previously announced 503A compounding agreement and telehealth infrastructure. On July 23 and 24, 2026, the FDA’s Pharmacy Compounding Advisory Committee voted in favour of six of the seven peptides it reviewed. Four of those six are used in the Company’s existing formulations.
This excerpt is quoted from the original release. Read the full announcement on Newsfile Corp.
Brief Summary
The Precision Peptide Company has officially launched nationwide retail sales, following positive recommendations from the FDA.
- Seven products available at precisionpeptidecompany.com
- First retail product: The Recovery Patch, a needle-free transdermal peptide.
- Orders now accepted from all 50 U.S. states.
- Enhanced consumer safety with LegitScript Healthcare Merchant Certification.
- GLP-1, Sermorelin, and NAD+ protocols to come soon.
Why it matters: This move underscores the company’s commitment to expanding accessibility within the peptide market and reflects confidence in FDA processes.
Read the Full Article
This is a summary of the press release. For the complete article and any additional details, please visit the original source.
Attribution: Original press release by Newsfile Corp on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.